Page last updated: 2024-11-05

delavirdine and Opioid-Related Disorders

delavirdine has been researched along with Opioid-Related Disorders in 1 studies

Delavirdine: A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.
delavirdine : The amide resulting from the formal condensation of 5-[(methylsulfonyl)amino]-1H-indole-2-carboxylic acid and 4-amino group of 1-[3-(isopropylamino)pyridin-2-yl]piperazine, delavirdine is a non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. Viral resistance emerges rapidly when delavirdine is used alone, so it is therefore used (as the methanesulfonic acid salt) with other antiretrovirals for combination therapy of HIV infection.

Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCance-Katz, EF1
Moody, DE1
Morse, GD1
Friedland, G1
Pade, P1
Baker, J1
Alvanzo, A1
Smith, P1
Ogundele, A1
Jatlow, P1
Rainey, PM1

Other Studies

1 other study available for delavirdine and Opioid-Related Disorders

ArticleYear
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4

    Topics: Adult; Alkynes; Area Under Curve; Benzoxazines; Buprenorphine; Case-Control Studies; Cohort Studies;

2006